13 research outputs found
CARD9<sup>+</sup> microglia promote antifungal immunity via IL-1ÎČ- and CXCL1-mediated neutrophil recruitment
This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Disease, National Institutes of Health, as well as NIH grants awarded to TMH (R01 093808), SGF (R01AI124566) and SRL (R01CA161373). Additional funding was provided by the Burroughs Wellcome Fund (awarded to TMH), the Wellcome Trust (102705, 097377; awarded to GDB), the MRC Centre for Medical Mycology and the University of Aberdeen (MR/N006364/1; awarded to GDB). The authors additionally thank Celeste Huaman for care and screening of the Malt1 793 -/- mice.Peer reviewedPostprin
Biological Earth observation with animal sensors
Space-based tracking technology using low-cost miniature tags is now delivering data on fine-scale animal movement at near-global scale. Linked with remotely sensed environmental data, this offers a biological lens on habitat integrity and connectivity for conservation and human health; a global network of animal sentinels of environmen-tal change
Recommended from our members
CARD9+ microglia promote antifungal immunity via IL-1ÎČ- and CXCL1-mediated neutrophil recruitment.
The C-type lectin receptor-Syk (spleen tyrosine kinase) adaptor CARD9 facilitates protective antifungal immunity within the central nervous system (CNS), as human deficiency in CARD9 causes susceptibility to fungus-specific, CNS-targeted infection. CARD9 promotes the recruitment of neutrophils to the fungus-infected CNS, which mediates fungal clearance. In the present study we investigated host and pathogen factors that promote protective neutrophil recruitment during invasion of the CNS by Candida albicans. The cytokine IL-1ÎČ served an essential function in CNS antifungal immunity by driving production of the chemokine CXCL1, which recruited neutrophils expressing the chemokine receptor CXCR2. Neutrophil-recruiting production of IL-1ÎČ and CXCL1 was induced in microglia by the fungus-secreted toxin Candidalysin, in a manner dependent on the kinase p38 and the transcription factor c-Fos. Notably, microglia relied on CARD9 for production of IL-1ÎČ, via both transcriptional regulation of Il1b and inflammasome activation, and of CXCL1 in the fungus-infected CNS. Microglia-specific Card9 deletion impaired the production of IL-1ÎČ and CXCL1 and neutrophil recruitment, and increased fungal proliferation in the CNS. Thus, an intricate network of host-pathogen interactions promotes antifungal immunity in the CNS; this is impaired in human deficiency in CARD9, which leads to fungal disease of the CNS
The Movebank system for studying global animal movement and demography
Quantifying movement and demographic events of free-ranging animals is fundamental to studying their ecology, evolution and conservation. Technological advances have led to an explosion in sensor-based methods for remotely observing these phenomena. This transition to big data creates new challenges for data management, analysis and collaboration.
We present the Movebank ecosystem of tools used by thousands of researchers to collect, manage, share, visualize, analyse and archive their animal tracking and other animal-borne sensor data. Users add sensor data through file uploads or live data streams and further organize and complete quality control within the Movebank system. All data are harmonized to a data model and vocabulary. The public can discover, view and download data for which they have been given access to through the website, the Animal Tracker mobile app or by API. Advanced analysis tools are available through the EnvDATA System, the MoveApps platform and a variety of user-developed applications. Data owners can share studies with select users or the public, with options for embargos, licenses and formal archiving in a data repository.
Movebank is used by over 3,100 data owners globally, who manage over 6 billion animal location and sensor measurements across more than 6,500 studies, with thousands of active tags sending over 3 million new data records daily. These data underlie >700 published papers and reports. We present a case study demonstrating the use of Movebank to assess life-history events and demography, and engage with citizen scientists to identify mortalities and causes of death for a migratory bird.
A growing number of researchers, government agencies and conservation organizations use Movebank to manage research and conservation projects and to meet legislative requirements. The combination of historic and new data with collaboration tools enables broad comparative analyses and data acquisition and mapping efforts. Movebank offers an integrated system for real-time monitoring of animals at a global scale and represents a digital museum of animal movement and behaviour. Resources and coordination across countries and organizations are needed to ensure that these data, including those that cannot be made public, remain accessible to future generations.DATA AVAILABILITY STATEMENT : White stork tracking and mortality data: Publicly available on Movebank in the âLifeTrack White Storkâ studies for Armenia (Study ID 10236270, Flack et al., 2015), Bavaria (ID 24442409, Fiedler, Flack, SchĂ€fle, et al., 2019), Greece (ID 10449535, Flack et al., 2015), Kosova (ID 175720577, Maxhuni et al., data to be published upon paper acceptance), Moscow (ID 10596067, Fiedler, Flack, SchĂ€fle, et al., 2019), Oberschwaben (ID 212096177, Fiedler et al., 2019b), Poland ECG (ID 25166516), Rheinland-Pfalz (ID 76367850, Fiedler, Hilsendegen, et al., 2019), Sicily (ID 79206236, Grasso et al., data to be published upon paper acceptance) and SW Germany (ID 21231406, Fiedler, Leppelsack, et al., 2019). Tracking data participating in the AAMA (Figure 5a): See data access instructions at www.movebank.org/cms/movebank-content/arctic-animal-movement-archive. MoveApps Apps and links to source code are publicly available from https://moveapps.org.Deutsches Zentrum fĂŒr Luft-
und Raumfahrt; Deutsche
Forschungsgemeinschaft;
Directorate for Biological Sciences;
Knobloch Family Foundation; Division of
Integrative Organismal Systems; Division of
Biological Infrastructure; National Aeronautics
and Space Administration; Ministerium fĂŒr
Wissenschaft, Forschung und Kunst
Baden-WĂŒrttemberg.http://www.wileyonlinelibrary.com/journal/mee3hj2022Veterinary Tropical Disease
Diapedesis-Induced Integrin Signaling via LFA-1 Facilitates Tissue Immunity by Inducing Intrinsic Complement C3 Expression in Immune Cells
Intrinsic complement C3 activity is integral to human T helper type 1 (Th1) and cytotoxic T cell responses. Increased or decreased intracellular C3 results in autoimmunity and infections, respectively. The mechanisms regulating intracellular C3 expression remain undefined. We identified complement, including C3, as among the most significantly enriched biological pathway in tissue-occupying cells. We generated C3-reporter mice and confirmed that C3 expression was a defining feature of tissue-immune cells, including T cells and monocytes, occurred during transendothelial diapedesis, and depended on integrin lymphocyte-function-associated antigen 1 (LFA-1) signals. Immune cells from patients with leukocyte adhesion deficiency type 1 (LAD-1) had reduced C3 transcripts and diminished effector activities, which could be rescued proportionally by intracellular C3 provision. Conversely, increased C3 expression by T cells from arthritis patients correlated with disease severity. Our study defines integrins as key controllers of intracellular complement, demonstrates that perturbations in the LFA-1-C3-axis contribute to primary immunodeficiency, and identifies intracellular C3 as biomarker of severity in autoimmunity
ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy
Eosinophils are an integral component of the pulmonary granulocyte response in Tuberculosis and promote host resistance in mice
Host resistance to Mycobacterium tuberculosis (Mtb) infection requires the activities of multiple leukocyte subsets, yet the roles of the different innate effector cells during tuberculosis are incompletely understood. Here we uncover an unexpected association between eosinophils and Mtb infection. In humans, eosinophils are decreased in the blood but enriched in resected human tuberculosis lung lesions and autopsy granulomas. An influx of eosinophils is also evident in infected zebrafish, mice, and nonhuman primate granulomas, where they are functionally activated and degranulate. Importantly, using complementary genetic models of eosinophil deficiency, we demonstrate that in mice, eosinophils are required for optimal pulmonary bacterial control and host survival after Mtb infection. Collectively, our findings uncover an unexpected recruitment of eosinophils to the infected lung tissue and a protective role for these cells in the control of Mtb infection in mice
Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition
Immune responses to infectious agents are initiated when a pathogen or its components bind to pattern recognition receptors (PRRs). PRR binding sets off a cascade of events that activates immune responses. We now show that, in addition to activating immune responses, PRR signaling also initiates an immunosuppressive response, probably to limit inflammation. The importance of the current findings is that blockade of immunomodulatory signaling, which is mediated by the upregulation of the CD47 molecule, can lead to enhanced immune responses to any pathogen that triggers PRR signaling. Since most or all pathogens trigger PRRs, CD47 blockade could be used to speed up and strengthen both innate and adaptive immune responses when medically indicated. Such immunotherapy could be done without a requirement for knowing the HLA type of the individual, the specific antigens of the pathogen, or, in the case of bacterial infections, the antimicrobial resistance profile.It is well understood that the adaptive immune response to infectious agents includes a modulating suppressive component as well as an activating component. We now show that the very early innate response also has an immunosuppressive component. Infected cells upregulate the CD47 âdonât eat meâ signal, which slows the phagocytic uptake of dying and viable cells as well as downstream antigen-presenting cell (APC) functions. A CD47 mimic that acts as an essential virulence factor is encoded by all poxviruses, but CD47 expression on infected cells was found to be upregulated even by pathogens, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that encode no mimic. CD47 upregulation was revealed to be a host response induced by the stimulation of both endosomal and cytosolic pathogen recognition receptors (PRRs). Furthermore, proinflammatory cytokines, including those found in the plasma of hepatitis C patients, upregulated CD47 on uninfected dendritic cells, thereby linking innate modulation with downstream adaptive immune responses. Indeed, results from antibody-mediated CD47 blockade experiments as well as CD47 knockout mice revealed an immunosuppressive role for CD47 during infections with lymphocytic choriomeningitis virus and Mycobacterium tuberculosis. Since CD47 blockade operates at the level of pattern recognition receptors rather than at a pathogen or antigen-specific level, these findings identify CD47 as a novel potential immunotherapeutic target for the enhancement of immune responses to a broad range of infectious agents
Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition.
It is well understood that the adaptive immune response to infectious agents includes a modulating suppressive component as well as an activating component. We now show that the very early innate response also has an immunosuppressive component. Infected cells upregulate the CD47 "don't eat me" signal, which slows the phagocytic uptake of dying and viable cells as well as downstream antigen-presenting cell (APC) functions. A CD47 mimic that acts as an essential virulence factor is encoded by all poxviruses, but CD47 expression on infected cells was found to be upregulated even by pathogens, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that encode no mimic. CD47 upregulation was revealed to be a host response induced by the stimulation of both endosomal and cytosolic pathogen recognition receptors (PRRs). Furthermore, proinflammatory cytokines, including those found in the plasma of hepatitis C patients, upregulated CD47 on uninfected dendritic cells, thereby linking innate modulation with downstream adaptive immune responses. Indeed, results from antibody-mediated CD47 blockade experiments as well as CD47 knockout mice revealed an immunosuppressive role for CD47 during infections with lymphocytic choriomeningitis virus and Mycobacterium tuberculosis Since CD47 blockade operates at the level of pattern recognition receptors rather than at a pathogen or antigen-specific level, these findings identify CD47 as a novel potential immunotherapeutic target for the enhancement of immune responses to a broad range of infectious agents.IMPORTANCE Immune responses to infectious agents are initiated when a pathogen or its components bind to pattern recognition receptors (PRRs). PRR binding sets off a cascade of events that activates immune responses. We now show that, in addition to activating immune responses, PRR signaling also initiates an immunosuppressive response, probably to limit inflammation. The importance of the current findings is that blockade of immunomodulatory signaling, which is mediated by the upregulation of the CD47 molecule, can lead to enhanced immune responses to any pathogen that triggers PRR signaling. Since most or all pathogens trigger PRRs, CD47 blockade could be used to speed up and strengthen both innate and adaptive immune responses when medically indicated. Such immunotherapy could be done without a requirement for knowing the HLA type of the individual, the specific antigens of the pathogen, or, in the case of bacterial infections, the antimicrobial resistance profile